Merck KGaA today announced the completion of an agreement to acquire the entire intellectual property (IP) portfolio of the company OLED-T with immediate effect. As we reported last month, OLED-T has gone into liquidation. We don't have any information on the financial side of this agreement.

OLED-T had an IP portfolio in the field of electron transport and phosphorescent-emitting materials for OLED application.

Tags:
Cambridge Isotope Laboratories - Deutreated Reagents and High-Purity Gases for OLEDsCambridge Isotope Laboratories - Deutreated Reagents and High-Purity Gases for OLEDs